MA26669A1 - 1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant

Info

Publication number: MA26669A1
Authority: MA; Morocco
Prior art keywords: naphtyridine; novels; arylmethyl; aryl; ones
Prior art date: 1998-08-11

Application number

MA25723A

Other languages

English (en)

Inventor

Fox Kleinman Edward

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-11

Filing date

1999-08-10

Publication date

2004-12-20

1999-08-10 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-12-20 Publication of MA26669A1 publication Critical patent/MA26669A1/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Virology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
AIDS & HIV (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

MA25723A 1998-08-11 1999-08-10 1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant MA26669A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US9617698P	1998-08-11	1998-08-11

Publications (1)

Publication Number	Publication Date
MA26669A1 true MA26669A1 (fr)	2004-12-20

Family

ID=22256080

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25723A MA26669A1 (fr)	1998-08-11	1999-08-10	1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (44)

Country	Link
US (1)	US6174895B1 (fr)
EP (1)	EP1104420B1 (fr)
JP (1)	JP2002522541A (fr)
KR (1)	KR20010072368A (fr)
CN (1)	CN1312810A (fr)
AP (1)	AP2001002068A0 (fr)
AR (1)	AR015557A1 (fr)
AT (1)	ATE229955T1 (fr)
AU (1)	AU4924999A (fr)
BG (1)	BG105321A (fr)
BR (1)	BR9912902A (fr)
CA (1)	CA2340180A1 (fr)
CO (1)	CO5130004A1 (fr)
CZ (1)	CZ2001485A3 (fr)
DE (1)	DE69904602T2 (fr)
DK (1)	DK1104420T3 (fr)
DZ (1)	DZ2866A1 (fr)
EA (1)	EA200100124A1 (fr)
EE (1)	EE200100085A (fr)
ES (1)	ES2188194T3 (fr)
GE (1)	GEP20033029B (fr)
GT (1)	GT199900128A (fr)
HK (1)	HK1038917A1 (fr)
HN (1)	HN1999000130A (fr)
HR (1)	HRP20010107A2 (fr)
HU (1)	HUP0103466A3 (fr)
ID (1)	ID27843A (fr)
IL (1)	IL140868A0 (fr)
IS (1)	IS5815A (fr)
MA (1)	MA26669A1 (fr)
NO (1)	NO20010684L (fr)
NZ (1)	NZ509297A (fr)
OA (1)	OA11591A (fr)
PA (1)	PA8480001A1 (fr)
PE (1)	PE20000950A1 (fr)
PL (1)	PL346005A1 (fr)
PT (1)	PT1104420E (fr)
SK (1)	SK1822001A3 (fr)
SV (1)	SV1999000120A (fr)
TN (1)	TNSN99155A1 (fr)
TR (1)	TR200100433T2 (fr)
TW (1)	TW542835B (fr)
WO (1)	WO2000009504A1 (fr)
ZA (1)	ZA200101040B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8815951B2 (en)	1996-08-13	2014-08-26	The Regents Of The University Of California	Inhibitors of epoxide hydrolases for the treatment of inflammation
JP2004532809A (ja) *	2000-11-02	2004-10-28	リサーチファウンデーションオブシティユニバーシティオブニューヨーク	ホスホジエステラーゼ４型を阻害することによって、神経系の再生および修復を刺激するための方法
WO2002088079A2 (fr) *	2001-05-01	2002-11-07	Bristol-Myers Squibb Company	Inhibiteurs doubles de pde 7 et pde 4
JO2311B1 (en) *	2001-08-29	2005-09-12	ميرك فروست كندا ليمتد	Alkyl inhibitors Ariel phosphodiesterase-4
WO2003077857A2 (fr) *	2002-03-15	2003-09-25	Merck & Co., Inc.	N-(benzyl substitue)-8-hydroxy-1,6-naphtyridine-7-carboxamides utiles comme inhibiteurs de l'integrase du vih
KR100454750B1 (ko) *	2002-06-20	2004-11-03	삼성에스디아이 주식회사	유기 전계 발광 소자용 청색 발광 화합물 및 이를 사용한유기 전계 발광 소자
CA2506949A1 (fr) *	2002-11-27	2004-06-10	Altana Pharma Ag	Inhibiteurs de pde4 et pde3/4 que l'on utilise dans le traitement de la cachexie
US6861422B2 (en) *	2003-02-26	2005-03-01	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
DE10349497A1 (de) *	2003-10-23	2005-05-25	Bayer Cropscience Ag	N-substituierte Pyrazolylcarboxanilide
JP2007517828A (ja) *	2004-01-17	2007-07-05	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	気道の疾患を治療するための置換プテリジンの使用
DE102004002557A1 (de) *	2004-01-17	2005-08-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
DE102004029784A1 (de) *	2004-06-21	2006-01-05	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) *	2004-07-09	2006-02-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US7728134B2 (en) *	2004-08-14	2010-06-01	Boehringer Ingelheim International Gmbh	Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US20060035903A1 (en) *	2004-08-14	2006-02-16	Boehringer Ingelheim International Gmbh	Storage stable perfusion solution for dihydropteridinones
US20060058311A1 (en)	2004-08-14	2006-03-16	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation
US20060074088A1 (en) *	2004-08-14	2006-04-06	Boehringer Ingelheim International Gmbh	Dihydropteridinones for the treatment of cancer diseases
US7759485B2 (en) *	2004-08-14	2010-07-20	Boehringer Ingelheim International Gmbh	Process for the manufacture of dihydropteridinones
EP1630163A1 (fr) *	2004-08-25	2006-03-01	Boehringer Ingelheim Pharma GmbH & Co.KG	Dihydropteridinones, procédés de préparation et leur utilisation en tant que médicaments
EP1632493A1 (fr) *	2004-08-25	2006-03-08	Boehringer Ingelheim Pharma GmbH & Co.KG	Dérivés de dihydropteridine, méthodes de préparation et utilisation en tant que médicament
DE102004058337A1 (de) *	2004-12-02	2006-06-14	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
WO2007014838A1 (fr) *	2005-08-03	2007-02-08	Boehringer Ingelheim International Gmbh	Dihydropteridinones utilisees pour le traitement de maladies respiratoires
US7439358B2 (en) *	2006-02-08	2008-10-21	Boehringer Ingelheim International Gmbh	Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
EP2185559A1 (fr) *	2007-08-03	2010-05-19	Boehringer Ingelheim International GmbH	Forme cristalline d'un dérivé de dihydroptéridione
US8546566B2 (en)	2010-10-12	2013-10-01	Boehringer Ingelheim International Gmbh	Process for manufacturing dihydropteridinones and intermediates thereof
US9358233B2 (en)	2010-11-29	2016-06-07	Boehringer Ingelheim International Gmbh	Method for treating acute myeloid leukemia
US9370535B2 (en)	2011-05-17	2016-06-21	Boehringer Ingelheim International Gmbh	Method for treatment of advanced solid tumors
CN104507912B (zh) *	2012-08-08	2016-09-28	默克专利股份公司	(氮杂-)异喹啉酮衍生物
US10154988B2 (en)	2012-11-14	2018-12-18	The Johns Hopkins University	Methods and compositions for treating schizophrenia
JP2016525532A (ja)	2013-07-26	2016-08-25	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	骨髄異形成症候群の処置
US9867831B2 (en)	2014-10-01	2018-01-16	Boehringer Ingelheim International Gmbh	Combination treatment of acute myeloid leukemia and myelodysplastic syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU165405B (fr) *	1972-06-29	1974-08-28
US3856800A (en) *	1973-02-26	1974-12-24	Sterling Drug Inc	Process of preparing 1,4-dihydro-4-oxo-7-q-3-unsubstituted-1,8-naphthyridines from cyclic alkylidenyl n-(6-q-2-pyridyl) aminomethylenemalonates
US3882132A (en) *	1973-03-08	1975-05-06	Sterling Drug Inc	Preparation of 1-alkyl-1,4-dihydro-7-substituted-4-oxo-1,8-naphthyridine-3-carboxylic acids via the 3-aminomethyl analogs
WO1996006843A1 (fr) *	1994-08-29	1996-03-07	Yamanouchi Pharmaceutical Co., Ltd.	Nouveau derive de naphtyridine et composition medicinale a base de ce derive
JP4323574B2 (ja) *	1995-12-13	2009-09-02	大日本住友製薬株式会社	抗腫瘍剤

1999
- 1999-08-05 EA EA200100124A patent/EA200100124A1/ru unknown
- 1999-08-05 AP APAP/P/2001/002068A patent/AP2001002068A0/en unknown
- 1999-08-05 TR TR2001/00433T patent/TR200100433T2/xx unknown
- 1999-08-05 HR HR20010107A patent/HRP20010107A2/hr not_active Application Discontinuation
- 1999-08-05 JP JP2000564956A patent/JP2002522541A/ja active Pending
- 1999-08-05 EP EP99933078A patent/EP1104420B1/fr not_active Expired - Lifetime
- 1999-08-05 EE EEP200100085A patent/EE200100085A/xx unknown
- 1999-08-05 HU HU0103466A patent/HUP0103466A3/hu unknown
- 1999-08-05 GE GEAP19995743A patent/GEP20033029B/en unknown
- 1999-08-05 PT PT99933078T patent/PT1104420E/pt unknown
- 1999-08-05 CA CA002340180A patent/CA2340180A1/fr not_active Abandoned
- 1999-08-05 IL IL14086899A patent/IL140868A0/xx unknown
- 1999-08-05 WO PCT/IB1999/001390 patent/WO2000009504A1/fr not_active Ceased
- 1999-08-05 AU AU49249/99A patent/AU4924999A/en not_active Abandoned
- 1999-08-05 CZ CZ2001485A patent/CZ2001485A3/cs unknown
- 1999-08-05 SK SK182-2001A patent/SK1822001A3/sk unknown
- 1999-08-05 KR KR1020017001718A patent/KR20010072368A/ko not_active Ceased
- 1999-08-05 DK DK99933078T patent/DK1104420T3/da active
- 1999-08-05 ID IDW20010315A patent/ID27843A/id unknown
- 1999-08-05 CN CN99809505A patent/CN1312810A/zh active Pending
- 1999-08-05 NZ NZ509297A patent/NZ509297A/en not_active Application Discontinuation
- 1999-08-05 DE DE69904602T patent/DE69904602T2/de not_active Expired - Fee Related
- 1999-08-05 HK HK02100400.2A patent/HK1038917A1/zh unknown
- 1999-08-05 BR BR9912902-7A patent/BR9912902A/pt not_active Application Discontinuation
- 1999-08-05 AT AT99933078T patent/ATE229955T1/de not_active IP Right Cessation
- 1999-08-05 ES ES99933078T patent/ES2188194T3/es not_active Expired - Lifetime
- 1999-08-05 OA OA1200100032A patent/OA11591A/en unknown
- 1999-08-05 PL PL99346005A patent/PL346005A1/xx not_active Application Discontinuation
- 1999-08-06 TW TW088113482A patent/TW542835B/zh active
- 1999-08-09 GT GT199900128A patent/GT199900128A/es unknown
- 1999-08-09 HN HN1999000130A patent/HN1999000130A/es unknown
- 1999-08-09 PE PE1999000802A patent/PE20000950A1/es not_active Application Discontinuation
- 1999-08-10 PA PA19998480001A patent/PA8480001A1/es unknown
- 1999-08-10 AR ARP990103992A patent/AR015557A1/es not_active Application Discontinuation
- 1999-08-10 TN TNTNSN99155A patent/TNSN99155A1/fr unknown
- 1999-08-10 SV SV1999000120A patent/SV1999000120A/es not_active Application Discontinuation
- 1999-08-10 DZ DZ990166A patent/DZ2866A1/fr active
- 1999-08-10 MA MA25723A patent/MA26669A1/fr unknown
- 1999-08-11 CO CO99051075A patent/CO5130004A1/es unknown
- 1999-08-11 US US09/372,735 patent/US6174895B1/en not_active Expired - Fee Related
2001
- 2001-01-16 IS IS5815A patent/IS5815A/is unknown
- 2001-02-07 ZA ZA200101040A patent/ZA200101040B/en unknown
- 2001-02-09 NO NO20010684A patent/NO20010684L/no not_active Application Discontinuation
- 2001-03-09 BG BG105321A patent/BG105321A/xx unknown

Also Published As

Publication number	Publication date
HRP20010107A2 (en)	2002-02-28
ZA200101040B (en)	2003-01-07
ES2188194T3 (es)	2003-06-16
SV1999000120A (es)	2000-09-05
SK1822001A3 (en)	2002-08-06
DK1104420T3 (da)	2003-01-13
CA2340180A1 (fr)	2000-02-24
US6174895B1 (en)	2001-01-16
AP2001002068A0 (en)	2001-03-31
PE20000950A1 (es)	2000-09-27
CN1312810A (zh)	2001-09-12
AU4924999A (en)	2000-03-06
NO20010684D0 (no)	2001-02-09
BG105321A (en)	2001-12-29
IS5815A (is)	2001-01-16
ATE229955T1 (de)	2003-01-15
DE69904602D1 (en)	2003-01-30
EP1104420A1 (fr)	2001-06-06
HK1038917A1 (zh)	2002-04-04
DZ2866A1 (fr)	2003-12-01
CO5130004A1 (es)	2002-02-27
NO20010684L (no)	2001-04-09
BR9912902A (pt)	2001-05-08
GT199900128A (es)	2001-01-30
KR20010072368A (ko)	2001-07-31
PL346005A1 (en)	2002-01-14
HUP0103466A3 (en)	2002-11-28
CZ2001485A3 (cs)	2002-05-15
DE69904602T2 (de)	2003-04-30
EA200100124A1 (ru)	2001-10-22
HUP0103466A2 (hu)	2002-02-28
OA11591A (en)	2004-07-30
ID27843A (id)	2001-04-26
EE200100085A (et)	2002-08-15
HN1999000130A (es)	2000-11-22
TW542835B (en)	2003-07-21
GEP20033029B (en)	2003-07-25
IL140868A0 (en)	2002-02-10
EP1104420B1 (fr)	2002-12-18
TNSN99155A1 (fr)	2005-11-10
TR200100433T2 (tr)	2001-07-23
PA8480001A1 (es)	2000-09-29
WO2000009504A1 (fr)	2000-02-24
PT1104420E (pt)	2003-03-31
JP2002522541A (ja)	2002-07-23
AR015557A1 (es)	2001-05-02
NZ509297A (en)	2003-11-28

Publication	Publication Date	Title
MA26622A1 (fr)	2004-12-20	Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26630A1 (fr)	2004-12-20	4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2780057B1 (fr)	2002-09-13	Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2866A1 (fr)	2003-12-01	1-Aryl-3-arylméthyl-1,8-naphtyridine-4-(1H)-ones nouvelles, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26654A1 (fr)	2004-12-20	Pyrrolopyrimidines nouvelles procede pour leur preparation et compositions pharmaceutiques les contenant
MA26479A1 (fr)	2004-12-20	Derives de nicotinamide, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26687A1 (fr)	2004-12-20	4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26465A1 (fr)	2004-12-20	Derives de quinoleine et derives de quinazoline nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26472A1 (fr)	2004-12-20	Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26468A1 (fr)	2004-12-20	Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26653A1 (fr)	2004-12-20	Pyrrolo [2,3- d] pyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26432A1 (fr)	2004-12-20	Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26598A1 (fr)	2004-12-20	4-(2-ceto-1-benzimidazolinyl) piperidines nouvelles, procede pour leur préparation et compositions pharmaceutiques les contenant
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26686A1 (fr)	2004-12-20	Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26712A1 (fr)	2004-12-20	Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2816938B1 (fr)	2003-01-03	Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant
MA24529A1 (fr)	1998-12-31	Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions les contenant .
MA26740A1 (fr)	2004-12-20	Derives de 13-methyl-erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26424A1 (fr)	2004-12-20	Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26559A1 (fr)	2004-12-20	Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
MA26730A1 (fr)	2004-12-20	Composes nouveaux antagonistes de npy, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26499A1 (fr)	2004-12-20	Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .
MA26433A1 (fr)	2004-12-20	Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26624A1 (fr)	2004-12-20	Derives de quinazolinamines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant